MAINZ BIOMED N V (MYNZ) - Price, trends, fundamentals and chart - Passport to Wall Street

MAINZ BIOMED N V (NASDAQ: MYNZ)

Overview

current price

$3.70

$3.70

change

0.17 | 4.82%

0.17 | 4.82%

Yesterday's Close

3.53

open

3.93

volume

2.57 M

30d. avg volume.

0.12 M

1 day

3.57 - 4.43

52 weeks

2.65 - 40.40

p/e

0.00

beta

0.5260

market cap

0.01 B

dividend yield

0.00%

Industry

-

News and Commentary

The Covid Era Tech Promises To Reinvent Cancer Treatment Pfizer Inc (PFE

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild their business, pharmaceutical companies like Pfizer...

mRNA Is Promising A Breakthrough In Fighting Cancer When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during...

The Pharmaceutical Industry Finds Itself At A Historical Crossroads Bristol Myers Squibb (BMY

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front On Thursday, Merck & Co Inc (M...

Pharma Continues Its Ongoing Battle Against Cancer Last Tuesday, Pfizer Inc (PFE

Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine Johnson & Johnson (JNJ&...

German Medical Companies Led 12 IPO Week November's initial public offering (IPO) market started off strong, with 12 traditional offering raising over $2 billion. However, the week ahead is expected to be explosive, wit...

November IPO Market Starts Hot with 12 Listings Planning to Raise $3.2 Billion in the Week Ahead The initial public offering (IPO) market plans to extend its momentum heading into November, with 12 traditional offers expected to raise nearly $3.2 billion.

StockTwits

StockTwits